Coastal Bridge Advisors, LLC Allogene Therapeutics, Inc. Transaction History

Coastal Bridge Advisors, LLC

$360 Million
Q3 2024

A detailed history of Coastal Bridge Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 405,847 shares of ALLO stock, worth $921,272. This represents 0.32% of its overall portfolio holdings.

Number of Shares

405,847

Previous 406,847 0.25%

Holding current value

$921,272

Previous $947,000 19.96%

% of portfolio

0.32%

Previous 0.27%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.08 - $3.5 $2,080 - $3,500	-1,000 Reduced 0.25%	405,847 $1.14 Million
Q4 2022 Feb 08, 2023	BUY	$5.62 - $11.11 $41,689 - $82,413	7,418 Added 1.86%	406,847 $2.56 Million
Q3 2022 Nov 15, 2022	SELL	$10.32 - $17.28 $25,800 - $43,200	-2,500 Reduced 0.62%	399,429 $4.31 Million
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $765,000 - $1.53 Million	100,000 Added 33.12%	401,929 $3.66 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $9,046 - $16,894	689 Added 0.23%	301,929 $4.51 Million
Q3 2021 May 20, 2022	SELL	$21.01 - $27.64 $21,010 - $27,640	-1,000 Reduced 0.33%	301,240 $7.74 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $21,010 - $27,640	-1,000 Reduced 0.33%	302,240 $7.77 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $2.13 Million - $3.22 Million	-82,584 Reduced 21.4%	303,240 $10.7 Million
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $1.6 Million - $2.75 Million	-63,272 Reduced 14.09%	385,824 $9.74 Million
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $453,999 - $630,384	-14,021 Reduced 3.03%	449,096 $16.9 Million
Q2 2020 Aug 11, 2020	SELL	$18.39 - $54.04 $3.81 Million - $11.2 Million	-207,305 Reduced 30.92%	463,117 $19.8 Million
Q1 2020 May 14, 2020	SELL	$18.22 - $28.25 $153,357 - $237,780	-8,417 Reduced 1.24%	670,422 $13 Million
Q4 2019 Feb 13, 2020	SELL	$24.82 - $31.4 $3.62 Million - $4.58 Million	-145,778 Reduced 17.68%	678,839 $17.6 Million
Q3 2019 Nov 08, 2019	SELL	$26.11 - $32.99 $8.65 Million - $10.9 Million	-331,100 Reduced 28.65%	824,617 $22.5 Million
Q2 2019 Aug 13, 2019	BUY	$25.56 - $31.09 $4.34 Million - $5.28 Million	169,940 Added 17.24%	1,155,717 $31 Million
Q2 2019 Aug 07, 2019	BUY	$25.56 - $31.09 $21.3 Million - $25.9 Million	832,259 Added 542.12%	985,777 $31 Million
Q1 2019 May 08, 2019	SELL	$24.82 - $32.54 $682,103 - $894,264	-27,482 Reduced 15.18%	153,518 $4.44 Million
Q4 2018 Feb 08, 2019	BUY	$22.5 - $33.3 $4.07 Million - $6.03 Million	181,000 New	181,000 $4.87 Million

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.

Account

Coastal Bridge Advisors, LLC Allogene Therapeutics, Inc. Transaction History